How many insider trades does FilingIQ track for ASMB?

FilingIQ tracks 173 Form 4 insider transactions for ASMB (ASSEMBLY BIOSCIENCES, INC.), covering filings from Jul 10, 2014 onwards. 9 of those were filed in the last 90 days.

Are ASMB insiders net buyers or net sellers?

Across the full Form 4 history for ASMB, 18 transactions (10%) were open-market purchases and 70 (40%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ASMB insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ASMB in?

ASSEMBLY BIOSCIENCES, INC. (ASMB) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $473.72M.

ASMB insider trading

NasdaqGS Healthcare

ASSEMBLY BIOSCIENCES, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

173

Last 90 days

Buys / sells

10% / 40%

Market cap

$473.72M

About ASSEMBLY BIOSCIENCES, INC.

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5336 and ABI-1179, which are in Phase 1a/1b clinical studies for recurrent genital herpes; ABI-4334, a capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus that is in Phase 1b clinical study; and ABI-6250, an orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical study. The company also develops ABI-7423, an oral broad-spectrum non-nucleoside polymerase inhibitor that targets transplant-related herpesviruses. It has an option, license, and collaboration agreement with Gilead Sciences, Inc. for the research and development of virology therapies. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

Company website: www.assemblybio.com

ASMB insider activity at a glance

FilingIQ has scored 173 insider transactions for ASMB since Jul 10, 2014. The most recent filing in our index is dated Mar 30, 2026.

Across the full history, 18 open-market purchases and 70 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ASMB insider trades is 55.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live ASMB trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for ASMB?: FilingIQ tracks 173 Form 4 insider transactions for ASMB (ASSEMBLY BIOSCIENCES, INC.), covering filings from Jul 10, 2014 onwards. 9 of those were filed in the last 90 days.
Are ASMB insiders net buyers or net sellers?: Across the full Form 4 history for ASMB, 18 transactions (10%) were open-market purchases and 70 (40%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ASMB insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ASMB in?: ASSEMBLY BIOSCIENCES, INC. (ASMB) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $473.72M.

Methodology & sources

Every ASMB insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.